Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia

Cancer

Volumn 78, Issue 2, 1996, Pages 330-336

  Bostwick, David G ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

adenocarcinoma; DNA ploidy; hyperplasia; neoplasms; premalignant; prostate; prostatic intraepithelial neoplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOMA; BASAL CELL; CARCINOMA IN SITU; CONFERENCE PAPER; DNA CONTENT; PLOIDY; PRECANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA;

ADENOCARCINOMA; ADULT; CARCINOMA; CELL DIVISION; CELL NUCLEOLUS; CELL NUCLEUS; DNA, NEOPLASM; HUMANS; MALE; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 0030018285     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO;2-W     Document Type: Conference Paper

References (67)

1. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
2. Bostwick DG. High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer 1995; 75:1823-36.
3. Sakr WA, Haas GP, Cassin BJ, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85.
4. McNeal JE, Villers A, Redwine EA, et al. Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol 1991;22:644-52.
5. Montironi R, Braccischi A, Matera G, Scarpelli M, Pisani E. Quantitation of prostatic intra-epithelial neoplasia. Analysis of the nuclear size, number and location. Pathol Res Pract 1990;187:307-14.
6. Helpap B. Observations on the number, size and location of nucleoli in hyperplastic and neoplastic prostatic disease. Histopathology 1988;13:203-11.
7. De La Torre M, Haggman M, Brandstedt S, et al. Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volume and DNA ploidy. Br J Urol 1993;72:207-13.
8. Petein M, Michel P, Van Velthoven R, et al. Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. Am J Clin Pathol 1991;96:628-34.
9. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987; 59:788-94.
10. Bostwick DG, Amin MB, Dundore P, et al. Architectural patterns of high grade prostatic intraepithelial neoplasia. Hum Pathol 1993;24:298-310.
11. Qian J, Wollan P, Bostwick DG. The extent and multicentricity of high grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol In press.
12. Ferguson J, Zincke H, Ellison E, et al. Decrease of prostatic intraepithelial neoplasia (PIN) following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology 1994;44:91-5.
13. Montironi R, Magi Galluzzi C, Scarpelli M, Giannulis I, Diamanti L. Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia. Virch Arch A Pathol Anat Histopathol 1993;423:351-7.
14. Arakawa A, Song S, Scardino PT, Wheeler TM. High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma. Pathol Res Pract 1995;191:868-72.
15. Boag AH, Young ID. Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Mod Pathol 1993;6:65-8.
16. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate In press.
17. Bostwick DG, Dousa MK, Crawford BG, Wollan PC. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Surg Pathol 1994;18:1240-6.
18. Colombel M, Symmans F, Gil S, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractoy human prostate cancers. Am J Pathol 1993;143:390-400.
19. Humphrey PA. Mucin in severe dysplasia in the prostate. Surg Pathol 1991;4:137-43.
20. Markham CW. Prostatic intraepithelial neoplasia. Detection and correlation with invasive cancer in fine-needle biopsy. Urology 1989;24(Suppl):57-61.
21. Maygarden SJ, Strom S, Ware JL. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 1992; 116:269-73.
22. McNeal JE, Leav I, Alroy J, Skutelsky E. Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia. Am J Clin Pathol 1988;89:41-8.
23. McNeal JE, Alroy J, Leav I, et al. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol 1988;90:23-32.
24. Montironi R, Magi Galluzzi C, Diamanti L, et al. Prostatic intra-epithelial neoplasia. Expression and location of proliferating cell nuclear antigen (PCNA) in epithelial, endothelial and stromal nuclei. Virchow Arch A Pathol Anat Histopathol 1993;422:185-92.
25. Myers RB, Srivastava S, Oelschlager DK, et al. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J Natl Cancer Inst 1994;86:1140-4.
26. Nagle RB, Brawer MK, Kittelson J, et al. Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 1991;138:119-28.
27. Perlman EJ, Epstein JI. Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Am J Surg Pathol 1990;14:810-8.
28. Gainnulis I, Montironi R, Galluzzi CM, et al. Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN). Anticancer Res 1993;13:2447-52.
29. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993;24:220-6.
30. Montironi R, Magi Galluzzi C, Diamanti L, et al. Prostatic intra-epithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Pathol Res Pract 1993;189:542-8.
31. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia (PIN). Cancer Res 1995;55:2959-62.
32. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, et al. Allelic loss in locally metastatic multisampled prostate cancer. Cancer fies 1994;54:3273-7.
33. Takahashi S, Qian J, Brown JA, et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 1994; 54:3574-9.
34. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol 1995;154:1791-4.
35. Mettlin C, Lee F, Drago J, Murphy GP, and the Investigators of the American Cancer Society National Prostate Cancer Detection Project. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991;67:2949-58.
36. Davidson D, Bostwick DG, Qian J, Siroky M, Rudders R, Stilmant M. Prostatic intraepithelial neoplasia is predictive of adenocarcinoma. J Urol 1995;154:1295-9.
37. Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, Lange PH. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 1991;38:103-7.
38. Berner A, Danielsen HE, Pettersen EO, Fossa SD, Reith A, Nesland JM. DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas. Anal Quant Cytol Histol 1993;15:247-52.
39. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ. Morphometric analysis and clinical follow-up of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 1995;154:347-51.
40. Weinstein MH, Epstein JI. Significance of high grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol 1993;24:624-9.
41. Alexander E, Qian J, Wollan P, Myers RP, Bostwick DG. Prostatic intraepithelial neoplasia does not raise serum prostate-specific antigen. Urology In press.
42. Ronnett BM, Carmichael MJ, Carter HB, et al. Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels? J Urol 1993;150:386-9.
43. Brawer MK, Lange PH. Prostate-specific antigen and premalignant change. Implications for early detection. CA Cancer J Clin 1989;39:361-75.
44. Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast T, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993;24:819-32.
45. Bostwick DG, Algaba F, Amin MB, et al. Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. Am J Surg Pathol 1994;18:1069-70.
46. Bostwick DG, Qian J. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 1995; 19:506-18.
47. Brawn PN, Speights VO, Contin JU, Bayardo RJ, Kuhl DL. Atypical hyperplasia in prostates of 20 to 40 year old men. J Clin Pathol 1989;42:383-6.
48. Gleason DF. Atypical hyperplasia, benign hyperplasia, and well-differentiated adenocarcinoma of the prostate. Am J Surg 1985;9:53-67.
49. Goldstein NS, Qian J, Bostwick DG. Mucin expression in atypical adenomatous hyperplasia of the prostate. Hum Pathol 1995;46:887-91.
50. Epstein JI, Fynheer J. Acidic mucin in the prostate: can it differentiate adenosis from adenocarcinoma? Hum Pathol 1992;23:1321-5.
51. Qian J, Bostwick DG, Jenkins RB. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Urology In press.
52. McNeal JE. The pathobiology of nodular hyperplasia. In: Bostwick DG, editor. Pathology of the prostate. New York: Churchill Livingstone, 1990:31-6.
53. Cheville JC, Bostwick DG. Post-atrophic hyperplasia of the prostate. A histologic mimick of prostatic adenocarcinoma. Am J Surg Pathol 1995;19:1068-76.
54. Grignon DJ, Ro JY, Ordonez NG, Ayala AG, Cleary KR. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. Hum Pathol 1988;19:1425-33.
55. Devaraj LT, Bostwick DG. Atypical basal cell hyperplasia of the prostate: immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol 1993; 17:645-59.
56. Epstein JI, Armas OA. Atypical basal cell hyperplasia of the prostate. Am J Surg Pathol 1992;16:1205-14.
57. Gagucas RJ, Brown RW, Wheeler TM. Verumontanum mucosal gland hyperplasia. Am J Surg Pathol 1995;19:30-6.
58. Gikas PW, Del Buono EA, Epstein JI. Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue: possible confusion with adenocarcinoma. Am J Surg Pathol 1992;16:454-9.
59. Collina G, Botticelli AR, Martinelli AM, Fano RA, Trentini GP. Sclerosing adenosis of the prostate. Report of three cases with electron microscopy and immunohistochemical study. Histopathology 1992;20:505-10.
60. Grignon DJ, Ro JY, Srigley JR, Troncoso P, Raymond AK, Ayala AG. Sclerosing adenosis of the prostate gland. A lesion showing myoepithelial differentiation. Am J Surg Pathol 1992;16:383-91.
61. Jones EC, Clement PB, Young RH. Sclerosing adenosis of the prostate gland. A clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol 1991;15:1171-80.
62. Sakamoto N, Tsuneyoshi M, Enjoji M. Sclerosing adenosis of the prostate. Histopathologic and immunohistochemical analysis. Am J Surg Pathol 1991;15:660-7.
63. Young RH, Clement PB. Sclerosing adenosis of the prostate. Arch Pathol Lab Med 1987;11:363-6.
64. Epstein JI. Adenosis vs. atypical adenomatous hyperplasia of the prostate [letter]. Am J Surg Pathol 1994;18:1070-1.
65. Srigley JR. Small-acinar patterns in the prostate gland with emphasis on atypical adenomatous hyperplasia and small-acinar carcinoma. Semin Diagn Pathol 1988;5:254-67.
66. Helpap B. The biological significance of atypical hyperplasia of the prostate. Virch Arch A Pathol Anat Histopathol 1980;387:307-17.
67. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992;70:291-301.